CFDE Data Portal | Search DUX4L37

	Label	Description
	DUX4L37 Gene (Entity type)	ENSG00000283020 - double homeobox 4 like 37 (pseudogene)
	GSE189035 inositol 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 9 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171988 MBNL knockout Schneider 1 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE152246 dihydrotestosterone 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 11 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS

DUX4L37

ENSG00000283020 - double homeobox 4 like 37 (pseudogene)

GSE189035 inositol 2 v 4 human dn

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 5 v 1 human dn

A Gene Set from LINCS

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 9 v 1 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 0 v 6 human up

A Gene Set from LINCS

GSE171988 MBNL knockout Schneider 1 1 v 3 human dn

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 5 v 4 human dn

A Gene Set from LINCS

GSE152246 dihydrotestosterone 0 v 1 human up

A Gene Set from LINCS

GSE48812 sulforaphane 11 v 6 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.